
The Nasdaq Biotechnology Index closed up over 2%
Component stock Oric Pharma rose by 33.50%, Erasca rose by 32.73%, and Tango Therapeutics rose by 20.10%, ranking third. LXRX (Laiskan Pharmaceutical) fell by 5.66%, ranking third in decline, Rapport Therapeutics fell by 10.46%, and Intellia Therapeutics also fell by 22.88%

